Company page
Medigen Biotechnology Corporation
Medigen Biotechnology Corporation, traded under the ticker 3176, is a public company based in Taiwan with a market capitalization of approximately 147 million USD. The company focuses on biotechnology innovations and developments. Medigen aims to advance healthcare solutions through its research and product offerings.
- Ticker
- 3176:TPEX
- Asset type
- Stock
- Market cap
- $147.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEX
- Currency
- TWD